New hope for tough brain tumors? early trial tests Drug-Radiation combo
NCT ID NCT04555577
Summary
This early-stage trial is testing a new drug called Peposertib, given alongside standard radiation and chemotherapy, for people newly diagnosed with a fast-growing type of brain tumor (glioblastoma). The main goals are to find the safest dose of Peposertib and see if it can get into the brain to help stop cancer cells from repairing themselves after radiation. Researchers hope this combination will work better than standard treatment alone to control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.